The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreAs Seen in Times of Israel
Technion scientist Assaf Zinger began wondering about breast milk when his wife, Noa, was breastfeeding their newborn daughter, Tamara, five years ago.
His wife had just received the COVID vaccine, and Tamara was starting to develop symptoms of the vaccine.
“I thought, ‘Hey, wait a minute, nanoparticles should degrade in the stomach,” Zinger told The Times of Israel in a teleconference call. “They should not be absorbed in the small intestine.”
After two years of research, Zinger said he believes that his team of 16 scientists is the first in the world to show that breast milk proteins can be used to protect and deliver nanoparticles so that people will be able to receive their medication — not by injecting it but by drinking it.